Targeted Therapies Changing AML Treatment Approaches Targeted medicine continues transforming the Acute Myeloid Leukemia Treatment Market by offering alternatives to traditional broad-spectrum treatments. Unlike chemotherapy, which affects rapidly dividing cells throughout the body, targeted therapies focus on specific abnormalities within leukemia cells. This precision reduces damage to healthy tissue. Patients with identified genetic mutations may receive oral medications designed to block abnormal signaling pathways. These treatments are often easier to administer compared to hospital-based therapies. Ref - https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223